{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:45:33Z","timestamp":1779914733957,"version":"3.53.1"},"reference-count":14,"publisher":"Elsevier","isbn-type":[{"value":"9780323989374","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.irn.2022.09.002","type":"book-chapter","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T03:11:14Z","timestamp":1666062674000},"page":"207-234","source":"Crossref","is-referenced-by-count":5,"title":["Challenges of translating a cell therapy to GMP"],"prefix":"10.1016","member":"78","reference":[{"issue":"5","key":"10.1016\/bs.irn.2022.09.002_bb0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/2643-3230.BCD-21-0084","article-title":"Scalable manufacturing of CAR T cells for cancer immunotherapy","volume":"2","author":"Abou-El-Enein","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"7","key":"10.1016\/bs.irn.2022.09.002_bb0015","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood.V89.7.2259","article-title":"Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes","volume":"89","author":"Bauer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/bs.irn.2022.09.002_bb0020","author":"CFR"},{"key":"10.1016\/bs.irn.2022.09.002_bb0025","author":"EudraLex"},{"issue":"5","key":"10.1016\/bs.irn.2022.09.002_bb0040","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.coi.2012.08.006","article-title":"Integration of retroviral vectors","volume":"24","author":"Gabriel","year":"2012","journal-title":"Current Opinion in Immunology"},{"issue":"6","key":"10.1016\/bs.irn.2022.09.002_bb0045","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1006\/mthe.2000.0077","article-title":"Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors","volume":"1","author":"Guenechea","year":"2000","journal-title":"Molecular Therapy"},{"issue":"9","key":"10.1016\/bs.irn.2022.09.002_bb0055","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/bs.irn.2022.09.002_bb0060","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.bmt.1700908","article-title":"CD34+ cell selection in chronic phase chronic myeloid leukaemia: A comparison of laboratory grade columns","volume":"20","author":"Hawkins","year":"1997","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1016\/bs.irn.2022.09.002_bb0065","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10162","article-title":"Hematopoietic stem cell transplantation\u201450 years of evolution and future perspectives","volume":"5","author":"Henig","year":"2014","journal-title":"Rambam Maimonides Medical Journal"},{"issue":"4","key":"10.1016\/bs.irn.2022.09.002_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cns.12839","article-title":"Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings","volume":"24","author":"Holley","year":"2018","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"5","key":"10.1016\/bs.irn.2022.09.002_bb0075","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","article-title":"Hematopoietic stem cell gene therapy: Progress and lessons learned","volume":"21","author":"Morgan","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/bs.irn.2022.09.002_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.stemcr.2017.11.005","article-title":"Human neural stem cell transplantation rescues functional deficits in R6\/2 and Q140 Huntington's disease mice","volume":"10","author":"Reidling","year":"2018","journal-title":"Stem Cell Reports"},{"issue":"4","key":"10.1016\/bs.irn.2022.09.002_bb0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nature Reviews. Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2022.09.002_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymgme.2008.12.016","article-title":"Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency","volume":"96","author":"Wilson","year":"2009","journal-title":"Molecular Genetics and Metabolism"}],"container-title":["International Review of Neurobiology","Current Challenges in Cell Therapy for Neurodegenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774222000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774222000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T12:49:40Z","timestamp":1753966180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774222000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323989374"],"references-count":14,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2022.09.002","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}